Guerbet SA Announces Sales Results for the First Quarter Ended March 31, 2019; Provides Sales Guidance for the Year 2019

Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (55.4%); - MRI products (32.7%); - other (11.9%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2023 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Europe accounts for 39.7% of net sales.